openPR Logo
Press release

Biogetica Announces Publication of Patents for Herpes Treatment

12-19-2016 10:10 AM CET | Health & Medicine

Press release from: Biogetica

Biogetica.com a collective of Doctors and Scientists dedicated to the mission of bringing nature back to medicine has announced the publication of various patents related to the natural treatment of oral and genital herpes.
Biogetica.com a collective of Doctors and Scientists dedicated to the mission of bringing nature back to medicine has announced the publication of various patents related to the natural treatment of oral and genital herpes.
The Indian Patent Office has published a patent number for Biogetica’s proprietary formulation Hyperisince that combines Hypericum Mysorense with other Anti-Viral Herbs and has a unique cellular delivery mechanism.
There is also a Patent Pending in USA that relates to the use of Hypericum Mysorense in a particular combination, as a Method of Treatment for Herpes and similar Patents applied for in India.
Hypericum Mysorense made international headlines when Indian Scientists at the JSS school of Pharmacology claimed that they had found a “cure for herpes” after a very promising in vitro study that showed 100% suppression of the Herpes Simplex Virus.
However, it was the Scientists and Doctors at Biogetica that invented a precise delivery mechanism and inter cellular transport for the Active Molecules of the formulation containing Hypericum Mysorense to work in Vivo.
Biogetica has also received approval from the AYUSH department of Ayurvedic, Unani, Siddha and Homeopathic Medicine for its products as an Ayurvedic Treatment for the Management of Herpes Simplex.
Numerous trials are ongoing for the treatment of Herpes with Hypericum Mysorense and the results thus far have been extremely promising.
Herpes Simplex is now considered to be the second most common virus on earth after the common cold. New research has shown that being infected with herpes triples ones chances of catching HIV. Antiviral creams or drugs like Acyclovir, Valtrex, Sorivudine, Famivir and/or Denavir only treat the symptoms of Herpes.
Antiviral drugs and other pharmaceutical attempts have not been able to cure herpes and those suffering are always in fear of passing the infection onto their lovers and children.
It is truly great to see these advancements in the field of natural medicine with relation to the HSV viruses. The patents and the results of trials are both great news for people suffering from globally.

Biogetica is a collective of Doctors, Scientists and Healers from numerous traditions including Ayurveda, Allopathy, Homeopathy. Yogic Sciences, Quantum Physics, Tibetan and Chinese Medicine.

Our Mission is to help people across the globe regain their health and freedom, utilizing nature's medicines. In doing so we wish to restore global respect in evidence based natural medicine as our Doctors recognize that returning to natural food and medicine is the only way we can live in ease and harmony.

We welcome you to our world of advanced healthcare which represents the modern approach to quantum healing. With offices in numerous countries and Drs from across the globe, you can rest assured that you are in capable and caring hands.

We are completely committed to creating a world where you never have to hear the words "there is no cure". We therefore make every effort to stay abreast with the latest research and ensure that every life we touch is uplifted in some way. Our marketing philosophy all along has been that 10 people will approach us for every single one that we help.

5730 Uplander Way, Suit #110
www.biogetica.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biogetica Announces Publication of Patents for Herpes Treatment here

News-ID: 397564 • Views:

More Releases for Herpes

Unlocking Prosperity: Drugs for Herpes Labialis (Oral Herpes) Market Insights
Dive into the pulse of 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬) 𝐌𝐚𝐫𝐤𝐞𝐭 trends with Growth Market Reports latest report! Gain a competitive edge with our in-depth analysis, uncovering market dynamics, consumer behaviors, and strategic imperatives. Let our expertise guide your decision-making and drive success in the ever-evolving landscape. Navigate the trends shaping the landscape and emerge with actionable insights to drive your business forward. Our comprehensive analysis offers a strategic
Market Mastery: Drugs for Herpes Labialis (Oral Herpes) Market Impact Beyond Exp …
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a leading authority in Market analysis, has released an extensive report on the Drugs for Herpes Labialis (Oral Herpes) Market. Tailored for clients seeking new Market dimensions, in-depth product insights, revenue optimization, and strategic reviews of key players, the report provides a roadmap for Market exploration. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬) 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐃𝐅 @ https://growthmarketreports.com/request-sample/7?utm=Openpr 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐛𝐲 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬) 𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭
Herpes Simplex Virus Treatment Market - Unlocking Relief, Conquering Herpes: Red …
Newark, New Castle, USA - new report, titled Herpes Simplex Virus Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Herpes Simplex Virus Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Herpes Simplex Virus Treatment market. The report offers
Herpes Labialis (Oral Herpes) Market SWOT Analysis by Key Players: BlueWillow Bi …
HTF Market Intelligence released a new research Study of 95 pages on title 'Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H1, 2021' with in-depth analysis, forecast and business moves. The study covers key regions that includes North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), Other Country (Middle East, Africa, GCC) and important players such as GlaxoSmithKline
Global Herpes Labialis (Oral Herpes) Drugs Market Future Analysis Report 2018-20 …
This report studies the global market size of Herpes Labialis (Oral Herpes) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Labialis (Oral Herpes) Drugs in these regions. This research report categorizes the global Herpes Labialis (Oral Herpes) Drugs market by players/brands, region, type and application. This report also studies the global market status, competition
Drugs For Herpes Labialis (Oral Herpes) Market Demand, Overview, Price and Forec …
ReportBazzar has released its latest research-based report entitled ‘Drugs For Herpes Labialis (Oral Herpes)’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Drugs For Herpes Labialis (Oral Herpes) market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Drugs For Herpes Labialis (Oral Herpes)